find in Esegui ricerca

Innovative Medicines Initiative (IMI) - EU


Established in 2007 as a €2 billion Joint Undertaking (JU) between the European Union (EU) and the European Federation of Pharmaceutical Industries and Associations (EFPIA), IMI is Europe's largest PPP in health research. It aims to speed up the development of better and safer medicines for patients. IMI funding activities will be concluded by 2014 and the IMI JU by 31 December 2017. On 10 July 2013, the European Commission released its proposal for IMI 2.
For whole article please register, is free.
This project has received funding from the European Union’s Seventh Programme for 
research, technological development and demonstration under grant agreement No 305128
  ENTENTE is supported by the European Commission and coordinated by Inserm-Transfert SA